Cargando…

Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa

The global emergence of multidrug-resistant (MDR) bacteria is a growing threat to public health worldwide. Natural bacteriophage lysins are promising alternatives in the treatment of infections caused by Gram-positive pathogens, but not Gram-negative ones, like Acinetobacter baumannii and Pseudomona...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hang, Wang, Mengyue, Yu, Junping, Wei, Hongping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686776/ https://www.ncbi.nlm.nih.gov/pubmed/26733995 http://dx.doi.org/10.3389/fmicb.2015.01471

Ejemplares similares

Engineering of lysin by fusion of antimicrobial peptide (cecropin A) enhances its antibacterial properties against multidrug-resistant Acinetobacter baumannii
por: Islam, Md Maidul, et al.
Publicado: (2022)

A Novel Acinetobacter baumannii Bacteriophage Endolysin LysAB54 With High Antibacterial Activity Against Multiple Gram-Negative Microbes
por: Khan, Fazal Mehmood, et al.
Publicado: (2021)

Engineered bacteriophage lysins as novel anti-infectives
por: Yang, Hang, et al.
Publicado: (2014)

Inhibitory Effect of Zinc Sulfate on Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii
por: Ramdas, Ishaan, et al.
Publicado: (2020)

Antimicrobial Activity of Poly-epsilon-lysine Peptide Hydrogels Against Pseudomonas aeruginosa
por: Kennedy, Stephnie M., et al.
Publicado: (2020)

Silver Nanocomposite Biosynthesis: Antibacterial Activity against Multidrug-Resistant Strains of Pseudomonas aeruginosa and Acinetobacter baumannii
por: Silva Santos, Klebson, et al.
Publicado: (2016)

Systemic Responses of Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Following Exposure to the Antimicrobial Peptide Cathelicidin-BF Imply Multiple Intracellular Targets
por: Liu, Cunbao, et al.
Publicado: (2017)

Novel Phage Lysin Abp013 against Acinetobacter baumannii
por: Chu, Joash Jun Keat, et al.
Publicado: (2022)

Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii
por: Peng, Jian, et al.
Publicado: (2019)

Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)

In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
por: Loho, Tonny, et al.
Publicado: (2018)

High-Throughput Identification of Antibacterials Against Pseudomonas aeruginosa
por: Li, Shijia, et al.
Publicado: (2020)

Plasmid-Mediated Fluoroquinolone Resistance in Pseudomonas aeruginosa and Acinetobacter baumannii
por: Venkataramana, Geetha P., et al.
Publicado: (2022)

Antibacterial activity of lysozyme-chitosan oligosaccharide conjugates (LYZOX) against Pseudomonas aeruginosa, Acinetobacter baumannii and Methicillin-resistant Staphylococcus aureus
por: Saito, Hiroaki, et al.
Publicado: (2019)

The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
por: Mwangi, James, et al.
Publicado: (2019)

A novel chimeric lysin with robust antibacterial activity against planktonic and biofilm methicillin-resistant Staphylococcus aureus
por: Yang, Hang, et al.
Publicado: (2017)

Pitfalls associated with evaluating enzymatic quorum quenching activity: the case of MomL and its effect on Pseudomonas aeruginosa and Acinetobacter baumannii biofilms
por: Zhang, Yunhui, et al.
Publicado: (2017)

In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

A unique antigen against SARS-CoV-2, Acinetobacter baumannii, and Pseudomonas aeruginosa
por: Rahbar, Mohammad Reza, et al.
Publicado: (2022)

A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
por: Mohamed, Mohamed F., et al.
Publicado: (2017)

Antimicrobial Activity of α-Peptide/β-Peptoid Lysine-Based Peptidomimetics Against Colistin-Resistant Pseudomonas aeruginosa Isolated From Cystic Fibrosis Patients
por: Molchanova, Natalia, et al.
Publicado: (2019)

Antibiofilm and Antivirulence Efficacies of Flavonoids and Curcumin Against Acinetobacter baumannii
por: Raorane, Chaitany Jayprakash, et al.
Publicado: (2019)

Mechanism of Action of Surface Immobilized Antimicrobial Peptides Against Pseudomonas aeruginosa
por: Yasir, Muhammad, et al.
Publicado: (2020)

Structure-Based Prototype Peptides Targeting the Pseudomonas aeruginosa Type VI Secretion System Effector as a Novel Antibacterial Strategy
por: Gao, Xiaopan, et al.
Publicado: (2017)

Green synthesis of silver nanoparticles using Ocimum sanctum Linn. and its antibacterial activity against multidrug resistant Acinetobacter baumannii
por: Gautam, Deepan, et al.
Publicado: (2023)

Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
por: Iregui, Alejandro, et al.
Publicado: (2020)

Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
por: Kim, Chung-Jong, et al.
Publicado: (2022)

Rapid identification of carbapenemase-producing Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii using a modified Carba NP test
por: Bakour, S., et al.
Publicado: (2015)

Assessment of Antibacterial and Anti-biofilm Effects of Vitamin C Against Pseudomonas aeruginosa Clinical Isolates
por: Abdelraheem, Wedad M., et al.
Publicado: (2022)

A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii
por: Chen, Sung-Pang, et al.
Publicado: (2021)

Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens
por: Tiwari, Vishvanath, et al.
Publicado: (2015)

Interaction of antibacterial compounds with RND eﬄux pumps in Pseudomonas aeruginosa
por: Dreier, Jürg, et al.
Publicado: (2015)

Antibiofilm property and multiple action of peptide PEW300 against Pseudomonas aeruginosa
por: Wang, Meng, et al.
Publicado: (2022)

The Mechanisms of Disease Caused by Acinetobacter baumannii
por: Morris, Faye C., et al.
Publicado: (2019)

The Transcriptomic Signature of Tigecycline in Acinetobacter baumannii
por: Li, Liping, et al.
Publicado: (2020)

Structure and Evolution of Acinetobacter baumannii Plasmids
por: Salgado-Camargo, Abraham D., et al.
Publicado: (2020)

Synergistic Antibacterial Activity of Combined Antimicrobials and the Clinical Outcome of Patients With Carbapenemase-Producing Acinetobacter baumannii Infection
por: Qu, Junyan, et al.
Publicado: (2020)

Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2022)

Delineating the Immuno-Dominant Antigenic Vaccine Peptides Against gacS-Sensor Kinase in Acinetobacter baumannii: An in silico Investigational Approach
por: Smiline Girija, A. S.
Publicado: (2020)

Apolipoprotein E mimetic peptide COG1410 combats pandrug-resistant Acinetobacter baumannii
por: Wang, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_32mnm5e5rl19a9e3e0hl6udob7